Literature DB >> 19132058

Micafungin: a sulfated echinocandin.

Seiji Hashimoto1.   

Abstract

Micafungin is the second approved antifungal agent in the echinocandin series and is now used worldwide in chemotherapy for life-threatening fungal infections. It is water-soluble and is semi-synthesized from the acylated cyclic hexapeptide FR901379, a natural product from the fungus Coleophoma empetri F-11899, through enzymatic deacylation of FR901379, followed by chemical reacylation with the optimized N-acyl side chain. The water solubility of micafungin is ascribed to a sulfate moiety in the molecule. This feature differentiates micafungin from other echinocandin members. Micafungin is a potent inhibitor of 1,3-beta-glucan synthase, an enzyme necessary for cell-wall synthesis of several fungal pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19132058     DOI: 10.1038/ja.2008.3

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  9 in total

1.  Occidiofungin's chemical stability and in vitro potency against Candida species.

Authors:  Dayna Ellis; Jiten Gosai; Charles Emrick; Rachel Heintz; Lanette Romans; Donna Gordon; Shi-En Lu; Frank Austin; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

2.  Evolution of Chemical Diversity in Echinocandin Lipopeptide Antifungal Metabolites.

Authors:  Qun Yue; Li Chen; Xiaoling Zhang; Kuan Li; Jingzu Sun; Xingzhong Liu; Zhiqiang An; Gerald F Bills
Journal:  Eukaryot Cell       Date:  2015-05-29

3.  Engineering of New Pneumocandin Side-Chain Analogues from Glarea lozoyensis by Mutasynthesis and Evaluation of Their Antifungal Activity.

Authors:  Li Chen; Yan Li; Qun Yue; Anna Loksztejn; Kenichi Yokoyama; Edd A Felix; Xingzhong Liu; Ningyan Zhang; Zhiqiang An; Gerald F Bills
Journal:  ACS Chem Biol       Date:  2016-08-10       Impact factor: 5.100

4.  Agrobacterium-tumefaciens-mediated transformation of antifungal-lipopeptide-producing fungus Coleophoma empetri F-11899.

Authors:  Masato Yamada; Kazunobu Yawata; Yohsuke Orino; Satoshi Ueda; Yasuhiro Isogai; Goro Taguchi; Makoto Shimosaka; Seiji Hashimoto
Journal:  Curr Genet       Date:  2009-10-30       Impact factor: 3.886

Review 5.  Structural Diversity and Biological Activities of Fungal Cyclic Peptides, Excluding Cyclodipeptides.

Authors:  Xiaohan Wang; Minyi Lin; Dan Xu; Daowan Lai; Ligang Zhou
Journal:  Molecules       Date:  2017-11-27       Impact factor: 4.411

6.  Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation.

Authors:  Gina Wall; Emily Chen; Mitchell V Hull; Jose L Lopez-Ribot
Journal:  Front Cell Infect Microbiol       Date:  2020-11-25       Impact factor: 5.293

Review 7.  Echinocandins: structural diversity, biosynthesis, and development of antimycotics.

Authors:  Wolfgang Hüttel
Journal:  Appl Microbiol Biotechnol       Date:  2020-12-03       Impact factor: 4.813

Review 8.  Cyclic peptide drugs approved in the last two decades (2001-2021).

Authors:  Huiya Zhang; Shiyu Chen
Journal:  RSC Chem Biol       Date:  2021-11-05

Review 9.  Echinocandins - structure, mechanism of action and use in antifungal therapy.

Authors:  Mateusz Szymański; Sandra Chmielewska; Urszula Czyżewska; Marta Malinowska; Adam Tylicki
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.